| Released | Contributor | Author | Title | Pages | Price |
|---|
| Jun 18, 2013 | New Constructs, LLC | N/A | PIP: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Jun 18, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-drugs | 18 | $207 | | Jun 17, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - PHARMATHENE INC NEW. (PIP-A) | 11 | $25 | | Jun 14, 2013 | Pechala's Reports | Frantisek Pechala | PHARMATHENE INC (PIP) 12-months forecast | 1 | $15 | | Jun 14, 2013 | Reuters Investment Profile | N/A | PharmAthene Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) | 105 | $1207.50 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) | 78 | $897 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) | 77 | $885.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ACUR , ANTH , LCI , OMER , PIP , SLXP -- DRUGS | 3 | $34.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: PHARMATHENE -- PIP | 1 | $11.50 |
|
View All Reports for PIP ... |
|
|
0.91%